ISPOR 14th annual European congress financial disclosure information for research presetnations

Download ISPOR 14th annual European congress financial disclosure information for research presetnations

Post on 30-Dec-2016

213 views

Category:

Documents

1 download

Embed Size (px)

TRANSCRIPT

  • ISPOR 14TH ANNUAL EUROPEAN CONGRESS FINANCIAL DISCLOSURE INFORMATION FOR RESEARCH PRESETNATIONS

    The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research.The following financial support was declared:

    ReferenceCode Financial Support

    ReferenceCode Financial Support

    AD1 NoneAD2 Janssen-Cilag SpA, Milano, ItalyAD3 NoneAD4 Mediguard, Rockville, MD, USA SACN1 Bristol-Myers Squibb, Wallingford, CT, USACN2 University of Twente, Enschede, The Netherlands; Sawtooth Software,

    Sequim, WA, USACN3 Pfizer Global Health Partnership, New York, NY, USA; EORTC Charitable

    Trust, Bruxelles, Belgium; King Baudouin Foundation, Bruxelles, Belgium;Belgian Cancer Foundation, Bruxelles, Belgium

    CN4 Briston-Myers Squibb, Princeton, NJ, USADA1 NoneDA2 ZonMw, Den Haag, The NetherlandsDA3 NoneDA4 NoneHG1 NoneHG2 NoneHG3 Health Research Board, Dublin, IrelandHG4 NoneHT1 NoneHT2 NoneHT3 Quintiles, Hoofddorp, The NetherlandsHT4 NoneMA1 Allergan, Irvine, CA, USAMA2 Janssen, High Wycombe, UKMA3 NoneMA4 NoneMO1 National Institute for Health Research, London, UKMO2 BMS, Brussels, BelgiumMO3 National Institute for Health Research, London, UKMO4 ZONMw, The Hague, The NetherlandsMT1 BMS, Plainsboro, NJ, USAMT2 NoneMT3 HTA Consulting, Cracow, PolandMT4 NoneNI1 NETSCC, Southampton, UKNI2 Medtronic, Tolochenaz, SwitzerlandNI3 NoneNI4 Eli Lilly, Indianapolis, IN, USAPCN1 Pfizer Oncology, New York, NY, USAPCN2 Bristol-Myers Squibb Canada, Montreal, QC, CanadaPCN3 NonePCN4 Eisai Inc., Woodcliff Lake, NJ, USAPCN5 Eisai Inc., Woodcliff Lake, NJ, USAPCN6 Eisai Inc., Woodcliff Lake, NJ, USAPCN7 Amgen, Brussels, BelgiumPCN8 NonePCN9 Amgen, Inc., Thousand Oaks, CA, USAPCN10 Amgen, Inc., Thousand Oaks, CA, USAPCN11 NonePCN12 BMS Spain, Madrid, SpainPCN13 iOMEDICO AG, Freiburg, GermanyPCN14 NonePCN15 NonePCN16 Novartis Pharmaceuticals Corporation, Florham Park, NJ, USAPCN17 Institute of Health Carlos III and Spanish Ministry of Health, Madrid, SpainPCN18 NonePCN19 Sanofi Pasteur MSD, Maidenhead, UKPCN20 Bristol-Myers Squibb , Lawrenceville, NJ, USAPCN21 Bristol-Myers Squibb, Lawrenceville, NJ, USAPCN22 NonePCN23 Janssen-Cilag Limited, High Wycombe, UKPCN24 NonePCN25 Fondo de Investigacion Sanitaria, Madrid, SpainPCN26 Takeda Global Research & Development Centre (Europe) Ltd., London, UKPCN27 NonePCN28 Evidencias, Campinas, BrazilPCN29 Evidencias, Campinas, BrazilPCN30 Abbott Laboratories, Abbott Park, IL, USAPCN31 Novartis Biociencias SA, Sao Paulo, BrazilPCN32 Croatian Society for Pharmacoeconomics and Health Economics, Zagreb,

    CroatiaPCN33 Amgen, Zug, SwitzerlandPCN34 Amgen, Zug, Switzerland

    PCN35 Evidencias, Campinas, BrazilPCN36 Canadian Institute for Health Research, Ottawa, ON, CanadaPCN37 ROCHE SAS, Neuilly Sur Seine, FrancePCN38 Genesis Pharma, Athens, GreecePCN39 Abbott Laboratories, Abbott Park, IL, USAPCN40 Amgen, Inc., Thousand Oaks, CA, USAPCN41 GlaxoSmithKline, Marly le Roi, FrancePCN42 NonePCN43 MSD, Moscow, RussiaPCN44 Sanofi Pasteur MSD, Maidenhead, UKPCN45 BMS, Rueil Malmaison, FrancePCN46 NonePCN47 NonePCN48 Novartis Biociencias SA, Sao Paulo, BrazilPCN49 NonePCN50 Pfizer Oncology, New York, NY, USAPCN51 Abbott, Abbott Park, IL, USAPCN52 Bristol-Myers Squibb, Brussels, BelgiumPCN53 Sanofi Pasteur MSD, Lyon, FrancePCN54 Janssen, Issy-les-Moulineaux, FrancePCN55 Genomic Health, Geneva, SwitzerlandPCN56 Genentech Inc., South San Francisco, CA, USAPCN57 NonePCN58 Janssen Cilag Farmaceutica, Sao Paulo, BrazilPCN59 NonePCN60 GlaxoSmithKline, Moscow, RussiaPCN61 AstraZeneca, Macclesfield, UKPCN62 GlaxoSmithKline Biologicals, Wavre, BelgiumPCN63 Pfizer Portugal, Porto Salvo, PortugalPCN64 NETSCC, London, UKPCN65 Novartis Pharmaceuticals Corporation, Florham Park, NJ, USAPCN66 Roche, Sao Paulo, BrazilPCN67 Roche, Sao Paulo, BrazilPCN68 Institut Paoli-Calmettes, Marseille, FrancePCN69 Roche Farma S.A., Madrid, SpainPCN70 Merck KGaA-Merck Serono, Darmstadt, GermanyPCN71 Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USAPCN72 GlaxoSmithKline, Madrid, SpainPCN73 Novartis Pharmaceuticals, East Hanover, NJ, USAPCN74 NonePCN75 Merck & Co., Inc., Whitehouse Station, NJ, USAPCN76 CONnective Tissue Cancers NETwork to integrate European Experience in

    Adult and Children -project no. LSHC-CT-2005-018806, BRUXELLES,Belgium; Clara, Lyon, France

    PCN77 Amgen, Neuilly-sur-Seine, FrancePCN78 ZonMw, Den Haag, The NetherlandsPCN79 Roche, Paris, FrancePCN80 NonePCN81 NonePCN82 Roche Hellas, Athens, GreecePCN83 NonePCN84 NonePCN85 NonePCN86 Roche Polska Sp. z o.o., Warsaw, PolandPCN87 MerckSerono UK, Feltham, UKPCN88 Amgen, Neuilly-sur-Seine, FrancePCN89 Merck & Co., Inc., Whitehouse Station, NJ, USAPCN90 NonePCN91 NonePCN92 Celgene, Lisboa, PortugalPCN93 The Netherlands Organization for Health Research and Development, Den

    Hague, The NetherlandsPCN94 NonePCN95 Merck & Co, Whitehouse Station, NJ, USAPCN96 NonePCN97 NonePCN98 Robert Koch Institute, Berlin, GermanyPCN99 Bristol-Myers Squibb, Paco de Arcos, PortugalPCN100 Ferring International, Saint-Prex, SwitzerlandPCN101 Janssen-Cilag, High Wycombe, UKPCN102 Astellas Pharma Europe, Staines, UKPCN103 Roche Products Limited, Welwyn Garden City, UKPCN104 Roche, Bucharest, RomaniaPCN105 Amgen-Hellas, Athens, Greece

    A511V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 5 1 1 - A 5 2 0

    Copyright 2011, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

  • PCN106 Dutch Health Care Insurance Board (CVZ), Diemen, The NetherlandsPCN107 NonePCN108 Pfizer China, Beijing, ChinaPCN109 NonePCN110 Astra Zeneka, Athens, GreecePCN111 NonePCN112 Ontario Cancer Research Network, Toronto, ON, CanadaPCN113 Janssen Korea, Seoul, South KoreaPCN114 Baxter Healthcare SA, Zurich, SwitzerlandPCN115 Amgen (Europe) GmbH, Zug, SwitzerlandPCN116 Amgen (Europe) GmbH, Zug, SwitzerlandPCN117 Amgen (Europe) GmbH, Zug, SwitzerlandPCN118 NonePCN119 F. Hoffmann-La Roche AG, Basel, SwitzerlandPCN120 GlaxoSmithKline, Collegeville, PA, USAPCN121 Pfizer, New York, NY, USAPCN122 Universiti Teknologi MARA (UiTM), Pulau Pinang, MalaysiaPCN123 Sanofi Pasteur MSD, Lyon, FrancePCN124 Medical Research Council, London, UKPCN125 Novartis Pharmaceuticals Corporation, Florham Park, NJ, USAPCN126 Pfizer Korea, Seoul, South KoreaPCN127 National University of Singapore, Singapore, SingaporePCN128 Sanofi-aventis, Bridgewater, NJ, USAPCN129 NonePCN130 Astellas Pharma, Leiderdorp, The NetherlandsPCN131 Instituto de Salud Carlos III, Madrid, Spain; AGAUR, Barcelona, SpainPCN132 NonePCN133 Kyung Hee University, Seoul, South KoreaPCN134 Boehringer Ingelheim GmbH, Ingelheim, GermanyPCN135 GlaxoSmithKline, Marly le Roi, FrancePCN136 Universiti Teknologi MARA (UiTM), Pulau Pinang, MalaysiaPCN137 GlaxoSmithKline, Espoo, Finland; The Finnish Cancer Organisations, Helsinki,

    FinlandPCN138 Roche Farma S.A., Madrid, SpainPCN139 NonePCN140 NonePCN141 Celgene Corporation, Summit, NJ, USAPCN142 NonePCN143 NonePCN144 NonePCN145 National Medical Research Council, Singapore, SingaporePCN146 NonePCN147 NonePCN148 Bristol-Myers Squibb, Uxbridge, UKPCN149 Pfizer, Sandwich, UKPCN150 Genentech Inc., S San Francisco, CA, USAPCN151 Bayer Schering Pharma AG, Berlin, GermanyPCN152 National Cancer Institute, NIH, Bethesda, MD, USAPCN153 NonePCN154 NonePCN155 Pfizer Ltd., Tadworth, UKPCN156 Eli Lilly, Indianapolis, IN, USAPCN157 Celgene Corporation, Cambridge, MA, USAPCN158 National Human Genome Research Institute, NIH, Bethesda, MD, USAPCN159 NonePCN160 Health Research Board (HRB), Dublin, IrelandPCN161 Bristol-Myers Squibb, Princeton, NJ, USAPCN163 NonePCN164 NonePCN165 Sanofi Pasteur MSD, Lyon, FrancePCN166 Pfizer Pharmaceuticals Korea Limited, Seoul, South KoreaPCN167 Pfizer, Inc, Seoul, South KoreaPCN168 NonePCN169 Groupement pour lElaboration et la Realisation de Statistique, Boulogne,

    FrancePCN170 NonePCN171 NonePCN173 NonePCN174 NonePCN175 Institut national dexcellence en sante et en services sociaux (INESSS),

    Quebec, QC, CanadaPCN176 NonePCN177 NonePCN178 NonePCN179 NonePCN180 NonePCN181 NonePCN182 National Cancer Center, Tokyo, JapanPCN183 ZonMw, Den Haag, The NetherlandsPCN184 NonePCN185 Pfizer Inc, New York, NY, USA

    PCN186 NonePCN187 Amgen, Inc., Thousand Oaks, CA, USAPCN188 Merck Serono, Darmstadt, Germany; Amgen, Munich, GermanyPCN189 Bristol-Myers Squibb Ltd., Uxbridge, UKPCN190 Institut national dexcellence en sante et en services sociaux (INESSS),

    Quebec, QC, Canada; Fonds de la recherche en sante du Quebec, Quebec,QC, Canada

    PCN191 Roche Korea, Seoul, South KoreaPCN192 NonePCN193 National Institute for Health Research, London, UKPCN194 NonePCN195 NonePCN196 NonePCN197 ZONMW, Den Haag, The NetherlandsPCN198 NonePCN199 AstraZeneca, Wilmington, DE, USAPCN200 Pfizer Oncology, New York, NY, USAPCN201 Qatar University, Doha, QatarPCV1 Bristol-Myers Squibb S.r.l., Rome, ItalyPCV2 NonePCV3 NonePCV4 Sanofi, Warsaw, PolandPCV5 NonePCV6 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

    Inc., Montgomery, AL, USAPCV7 Pfizer, Madrid, SpainPCV8 Otsuka America Pharmaceutical, Inc., Rockville, MD, USAPCV9 Daiichi Sankyo, Inc., Tokyo, Japan; Eli Lilly and Company, Indianapolis, IN,

    USAPCV10 Abbott Labs, Abbott Park, IL, USAPCV11 Daiichi Sankyo, Inc., Tokyo, Japan; Eli Lilly and Company, Indianapolis, IN,

    USAPCV12 Pfizer Ltd., Surrey, UKPCV13 AstraZeneca, Wilmington, DE, USAPCV14 sanofi, Sydney, AustraliaPCV15 NonePCV16 NonePCV17 Actelion, Moscow, RussiaPCV18 The Medicines Company, Abingdon, UKPCV19 NonePCV20 NonePCV21 NonePCV22 NonePCV23 AstraZeneca UK Ltd., Luton, UKPCV24 NonePCV25 MSD Ltd., Hertford Road, Hoddesdon, Hertfordshire, UKPCV26 NonePCV27 NonePCV28 NonePCV29 Amgen Inc., Thousand Oaks, CA, USAPCV30 Amgen Inc., Thousand Oaks, CA, USAPCV31 NonePCV32 AstraZenca, Wilmington, DE, USAPCV34 Daiichi Sankyo, Inc., Parsippany, NJ, USAPCV35 NonePCV36 GlaxoSmithKline, London, UKPCV37 Novonordisk, Malm, SwedenPCV38 AstraZeneca, Wilmington, DE, USAPCV39 Pfizer, Berlin, Germany; Bristol-Myers Squibb, Muenchen, GermanyPCV40 MSD, Madrid, SpainPCV41 GE Healthcare, Chalfont St Giles, UKPCV42 Daiichi-Sankyo Europe GmbH, Munich, GermanyPCV43 NonePCV44 Roche Diagnostics, Vienna, AustriaPCV45 Astrazeneca, Madrid, SpainPCV46 NonePCV47 NonePCV48 NonePCV49 NonePCV50 Sanofi-Aventis, Montreal, QC, CanadaPCV51 AstraZeneca, Zug, SwitzerlandPCV52 Sanofi-aventis, Guildford, UKPCV53 Medtronic, Madrid, SpainPCV54 NonePCV55 NonePCV56 SANOFI-AVENTIS, Athens, GreecePCV57 Bhringer Ingelheim, Vienna, AustriaPCV58 Institute for Health Economics and Policy, Tokyo, JapanPCV59 Merck & Co, Inc, Whitehouse Station, NJ, USAPCV60 Boehringer ingelheim Pty Limited, North Ryde, AustraliaPCV61 Boehringer Ingelheim, Barcelona, Spain

    ReferenceCode Financial Support

    ReferenceCode Financial Support

    A512 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 5 1 1 - A 5 2 0

  • PCV62 Pfizer, Madrid, SpainPCV63 Boehringer Ingelheim, Madrid, SpainPCV64 NonePCV65 NonePCV66 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

    Inc., Montgomery, AL, USAPCV67 National Insitute for Food and Nutrition Science, Budapest, HungaryPCV68 Medco Health Solutions, Franklin Lakes, NJ, USAPCV69 Sanofi-Aventis, Gouda, The NetherlandsPCV70 AstraZeneca GmbH, Wedel, GermanyPCV71 NonePCV72 AstraZeneca Pharma Poland, Warsaw, PolandPCV73 NIHR Health Technology Assessment Programme, Southampton, UKPCV74 National Institute of Health Research, London, UKPCV75 NonePCV76 SANOFI-AVENTIS, Athens, GreecePCV77 Boehringer Ingelheim Hellas, Athens, GreecePCV78 SANOFI-AVENTIS, Athens, GreecePCV79 Astra Zeneka, Athens, GreecePCV80 NonePCV81 AstraZeneca Canada, Toronto, ON, CanadaPCV82 Novartis Pharma AG, Basel, SwitzerlandPCV83 AstraZeneca, Athens, GreecePCV84 Takeda, Vienna, AustriaPCV85 NonePCV86 AstraZeneca, Wilmington, DE, USAPCV87 Astra Zeneca, Zoetermeer, The NetherlandsPCV88 AstraZeneca, Wilmington, DE, USAPCV89 Astrazeneca, Madrid, SpainPCV90 Transition Patient Services, Shrewsbury, NJ, USAPCV91 Instituto de Salud Carlos III, Madrid, SpainPCV92 Grupo Menarini, Barcelona, SpainPCV93 NonePCV94 sanofi australia pty Ltd., Sydney, AustraliaPCV95 SINOPEC, Port Harcourt, NigeriaPCV96 NonePCV97 New Zealand Ministry of Health, Wellington, New ZealandPCV98 NonePCV99 NonePCV100 AstraZeneca UK, Luton, UKPCV101 IRSC, Montreal, QC, CanadaPCV102 Novartis, Emmaus, PA, USAPCV103 Ministry of Higher Education, Malaysia, Malaysia, MalaysiaPCV104 Daiichi Sankyo Europe GmbH, Munich, GermanyPCV105 Pfizer, New York, NY, USAPCV106 NonePCV107 NonePCV108 sanofi, Sydney, AustraliaPCV109 Silpakorn University Research and Development Institute, Nakhon Pathom,

    ThailandPCV110 Boehringer Ingelheim, Ingelheim, GermanyPCV111 Merck, Sharp & Dohme, Whitehouse Station, NJ, USAPCV112 Daiichi Sankyo Europe GmbH, Munich, GermanyPCV113 Daiichi Sankyo Europe GmbH, Munich, GermanyPCV114 NIHR Heallth Technology Assessment Programme, Southampton, UKPCV115 NonePCV116 Kantar Health, Princeton, NJ, USAPCV117 Daiichi Sankyo Europe, Munich, GermanyPCV118 Shire , Boulogne Billancourt, FrancePCV119 Novartis Farmaceutica, S.A., Barcelona, SpainPCV120 Medtronic, Madrid, SpainPCV121 Novartis Pharma AG, Basel, SwitzerlandPCV122 Servier, Lyon, FrancePCV123 NonePCV124 The Social Insurance Institution, Helsinki, FinlandPCV125 Sanofi-Aventis, Guildford, UKPCV126 HTA Consulting, Krakow, Poland; Sequence HC Partners, Warszawa, PolandPCV127 Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USAPCV128 Bayer, Newbury, UKPCV129 Servier Poland, Warsaw, PolandPCV131 NonePCV132 Boehringer Ingelheim, Ingelheim am Rhein, GermanyPCV133 NonePCV134 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

    Inc., Montgomery, AL, USAPCV135 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

    Inc., Montgomery, AL, USAPCV136 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

    Inc., Montgomery, AL, USAPCV137 NonePCV138 None

    PCV139 Boehringer Ingelheim, Sao Paulo, BrazilPCV140 Ministry of Health & Welfare, Seoul, South KoreaPCV141 Eli-Lilly and Co Greece, Athens, GreecePCV142 NonePCV144 Bayer Schering Pharma AG, Wuppertal, GermanyPCV145 NonePCV146 NonePCV147 NonePCV148 NonePC1 Lundbeck SAS, Issy-les-Moulineaux, FrancePC2 NonePC3 Health Research Board, Dublin, Ireland; Irish Cancer Society, Dublin, IrelandPC4 Instituto de Salud Carlos III, ISCIII GR09/0026, Madrid, SpainPDB1 NonePDB2 NonePDB3 sanofi-aventis, Montreal, QC, CanadaPDB4 Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USAPDB5 Sanofi-Aventis, Berlin, GermanyPDB6 Eli Lilly and Company, Indianapolis, IN, USAPDB7 Sanofi-Aventis, Laval, QC, CanadaPDB8 Lilly and Co. Ltd., Indianapolis, IN, USA; Amylin Pharmaceuticals Inc, San

    Diego, CA, USAPDB9 Bristol-Meyers Squibb, Princeton, NJ, USAPDB10 Amylin Pharmaceuticals, Inc., San Diego, CA, USA; Eli Lilly and Company,

    Indianapolis, IN, USAPDB11 Amylin Pharmaceuticals, Inc., San Diego, CA, USAPDB12 sanofi-aventis, Bridgewater, NJ, U...

Recommended

View more >